The largest database of trusted experimental protocols

Iscove s modified dulbecco s medium

Manufactured by Nacalai Tesque
Sourced in United States

Iscove's modified Dulbecco's medium is a cell culture medium formulation designed for the cultivation of a variety of cell types. It provides a defined and balanced combination of nutrients, vitamins, and other components essential for cell growth and maintenance.

Automatically generated - may contain errors

4 protocols using iscove s modified dulbecco s medium

1

SK-MEL-2 Luciferase Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
SK-MEL-2 cells containing the Luc gene (JCRB cell bank) were maintained at 37 °C in a humidified 5% CO2 incubator using RPMI1640 culture medium (FUJIFILM Wako Pure Chemical) containing 10% heat-inactivated fetal calf serum (Sigma–Aldrich), 100 U/ml penicillin, and 100 μl/ml streptomycin (Nacalai Tesque) in 10 cm dish (Thermo Fisher Scientific). Dulbecco’s modified Eagle’s medium (FUJIFILM Wako Pure Chemical) or Iscove’s modified Dulbecco’s medium (Nacalai Tesque) was used to maintain A549 or HAP1 cells as previously described (16 (link), 25 (link)). Zinc-supplementation experiments involved adding the indicated concentrations of ZnSO4 (Nacalai Tesque) to the cell culture medium.
+ Open protocol
+ Expand
2

Cell culture conditions for various cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293 cells (ATCC CRL-1573), HT-29 cells (ATCC HTB-38), U-251 MG cells (CVCL_0021), SH-SY5Y cells (ATCC CRL-2266), HeLa cells (ATCC CCL-2), and their KO derivatives were cultured in Dulbecco's Modified Eagle Medium (DMEM) with high glucose (Nacalai Tesque). Raji cells (ATCC CCL-86), THP-1 cells (ATCC TIB-202), K-562 cells (ATCC CCL-243), and their derivatives were cultured in RPMI medium 1640 (Nacalai Tesque). HAP1 cells (kindly provided by Thijn Brummelkamp, The Netherlands Cancer Institute, Amsterdam, The Netherlands) and their KO derivatives were cultured in Iscove's Modified Dulbecco's Medium (Nacalai Tesque). CHO (Chinese Hamster Ovary) K1 cells (ATCC CCL-61) and their derivatives were maintained in DMEM/F-12 (Nacalai Tesque). All cell culture medium contained 10% heat-inactivated fetal bovine serum (FBS) (172012-500ML, Sigma). All cells were maintained in an incubator at 37 °C and 5% CO2.
+ Open protocol
+ Expand
3

FUS-ERG Fusion Protein and Azacitidine Sensitivity

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the association between FUS-ERG and Aza sensitivity, we established haematopoietic cells stably expressing FUS-ERG (Additional file 1; Figure S1). Ba/F3 cells were authenticated using short tandem repeat analysis by the American Type Culture Collection (Manassas, VA, USA) and grown in Iscove's modified Dulbecco's medium (Nacalai, Kyoto, Japan) supplemented with 20% foetal bovine serum, 20% WEHI supernatant, and 1% penicillin/streptomycin in a humidified atmosphere containing 5% carbon dioxide at 37 °C. WEHI cells were cultured in high-glucose-containing Dulbecco's modified eagle medium (Nacalai) supplemented with 10% foetal bovine serum, 5 × 10–5 M β-mercaptoethanol, and 1% penicillin/streptomycin. The supernatant was collected after centrifugation and 0.22 µm filtration for cytokine supplementation. The full length of FUS-ERG was amplified from the cDNA of the patient sample using the primers GGTACTCAGCGGTGTTGGAA and CTTCCCCAGCCCCAGTAAAG and constructed into pcDNA3.1. cDNA was synthesised from the total RNA using SuperScript III Reverse Transcriptase (Invitrogen, Waltham, MA, USA). Total RNA was isolated using an RNeasy Mini Kit (Qiagen, Hilden, Germany). FUS-ERG-transduced Ba/F3 cells were established using Nucleofector by Amaxa (Lonza, Basel, Switzerland) and selected with 1 mg/ml G418 (Nacalai).
+ Open protocol
+ Expand
4

Cell Line Cultivation for Antibody Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines. The human pancreatic cancer cell line BxPC3 was purchased from the American Type Culture Collection (Manassas, VA, USA). The human colon cancer cell line Colo205 was purchased from DS Pharma Biomedical (Osaka, Japan). These cells were maintained in RPMI-1640 medium (Nakalai tesque, Kyoto, Japan) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Gibco, Grand Island, NY, USA) and 50 μg/ml gentamicin (Nakalai tesque). The Chinese hamster ovary cell line CHO/DG44 was a kind gift from Dr. Lawrence Chasin (Columbia University, New York, NY, USA) and maintained in iscove's modified dulbecco's medium (Nakalai tesque) supplemented with 10% dialyzed FBS (Gibco), HT supplement (Gibco) and 50 μg/ml gentamicin. CHO-K1 was purchased from RIKEN (Tsukuba, Japan) and maintained in EX-CELL325PF CHO serum-free medium (Sigma, St. Louis, MO, USA) supplemented with 6 mM Lglutamine (Nakalai tesque) and 50 μg/ml gentamicin. An α-1,6fucosyltransferase (FUT8)-knockout CHO cell line, FUT8 -/-CHO, for defucosylated antibody production was developed at Kyowa Hakko Kirin Co., Ltd., as previously described (14) .
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!